|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Biosorption of Hg (Ⅱ) and Cd (Ⅱ) from Waste Water by using Zea Mays Waste显示文摘 | Jamil N Munawar MA Badar S | 2009 | Journal of the Chemical Society of Pakistan2009，31，3： | 1 |
| 2 | Imperforate hymen : report of an un- usual familial occurrence 显示文摘 | Lim YH Ng SP Jamil MA | 2003 | J Obstet Gynecol Res2003，29，6： | 1 |
| 3 | Risk Perceptions and Barriers to Hepatitis B Screening and Vaccination among Vietnamese Immigrants显示文摘 | Grace X. Ma Carolyn Y. Fang Steven E. Shive Jamil Toubbeh Yin Tan Philip Siu | 2007 | Journal of Immigrant and Minority Health2007，，3： | 1 |
| 4 | Cardiovascular effects of copper deficiency on activity of superoxide dismutase in diabetic nephropathy 显示文摘 | Al-Bayati MA Jamil DA Al-Aubaidy HA | 2015 | N Am J Med Sci2015，7，2： | 1 |
| 5 | Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population显示文摘AIM:To derive a Malaysia guideline and consensus as part of the Malaysia Retina Group's efforts for diagnosis,treatment,and best practices of diabetic macular edema(DME).The experts'panel suggests that the treatment algorithm to be divided into groups according to involvement the central macula.The purpose of DME therapy is to improve edema and achieve the best visual results with the least amount of treatment load.METHODS:On two different occasions,a panel of 14 retinal specialists from Malaysia,together with an external expert,responded to a questionnaire on management of DME.A consensus was sought by voting after compiling,analyzing and discussion on first-phase replies on the round table discussion.A recommendation was deemed to have attained consensus when 12 out of the 14 panellists(85%)agreed with it.RESULTS:The terms target response,adequate response,nonresponse,and inadequate response were developed when the DME patients'treatment responses were first characterized.The panelists reached agreement on a number of DME treatment-related issues,including the need to classify patients prior to treatment,firstline treatment options,the right time to switch between treatment modalities,and side effects associated with steroids.From this agreement,recommendations were derived and a treatment algorithm was created.CONCLUSION:A detail and comprehensive treatment algorithm by Malaysia Retina Group for the Malaysian population provides guidance for treatment allocation of patients with DME. | Nor Fariza Ngah Nor Asiah Muhamad Shelina Oli Mohamed Roslin Azni Abdul Aziz Nur Hasnah Ma’amor Nor Azita Ahmad Tarmidzi Hanizasurana Hashim Hamisah Ishak Wan Norliza Wan Muda Rosiah Muda Azian Adnan Rafidah Md Saleh Wong Hon Seng Nurfahzura Mohd Jamil Tara Mary George Adrian Koh | 2023 | International Journal of Ophthalmology(English edition)2023，16，5： | 0 |
| 6 | Label-free impedimetric immunosensor for point-of-care detection of COVID-19 antibodies显示文摘The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to detect and monitor pathogens.Therefore,there is a need to develop point-of-care(POC)devices to perform fast,accurate,and accessible diagnostic methods to detect infections and monitor immune responses.Devices most amenable to miniaturization and suitable for POC applications are biosensors based on electrochemical detection.We have developed an impedimetric immunosensor based on an interdigitated microelectrode array(IMA)to detect and monitor SARS-CoV-2 antibodies in human serum.Conjugation chemistry was applied to functionalize and covalently immobilize the spike protein(S-protein)of SARS-CoV-2 on the surface of the IMA to serve as the recognition layer and specifically bind anti-spike antibodies.Antibodies bound to the S-proteins in the recognition layer result in an increase in capacitance and a consequent change in the impedance of the system.The impedimetric immunosensor is label-free and uses non-Faradaic impedance with low nonperturbing AC voltage for detection.The sensitivity of a capacitive immunosensor can be enhanced by simply tuning the ionic strength of the sample solution.The device exhibits an LOD of 0.4 BAU/ml,as determined from the standard curve using WHO IS for anti-SARS-CoV-2 immunoglobulins;this LOD is similar to the corresponding LODs reported for all validated and established commercial assays,which range from 0.41 to 4.81 BAU/ml.The proof-of-concept biosensor has been demonstrated to detect anti-spike antibodies in sera from patients infected with COVID-19 within 1 h. | Lian C.T.Shoute Gaser N.Abdelrasoul Yuhao Ma Pedro A.Duarte Cole Edwards Ran Zhuo Jie Zeng Yiwei Feng Carmen L.Charlton Jamil N.Kanji Shawn Babiuk Jie Chen | 2023 | Microsystems & Nanoengineering2023，9，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员